Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NGR-hTNF +/- Doxorubicin in Advanced STS
NCT00484341Phase 2Completed
- Sponsor
- AGC Biologics
- Start
- Oct 2010
- Primary completion
- May 2016
- Modality
- Peptides, Fc-Fusion Proteins
- Countries
- 3
01
Overview
A Phase 2 trial of NGR-TNF in soft tissue sarcoma (STS), sponsored by AGC Biologics. Started Oct 2010; status: completed.
02
Drugs
NGR-TNF
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00484341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00484341.